Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males

BACKGROUND: In pregnant women, the use of Mycophenolic acid (MPA) is associated with teratogenicity. Recently, the European Medicines Agency (EMEA) and the Spanish Agency of Medicine and Sanitary Products (AEMPS) warned about the potential teratogenic effects of MPA. These adverse events may occur e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Lopez, Isabel, Rodelo-Haad, Cristian, Agüera, Maria Luisa, Cabello-Jabalquinto, Rosario, Esquivias-Motta, Elvira, Navarro, M. Dolores, Aljama, Pedro, Rodriguez-Benot, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135357/
https://www.ncbi.nlm.nih.gov/pubmed/30208043
http://dx.doi.org/10.1371/journal.pone.0202589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135357/
https://www.ncbi.nlm.nih.gov/pubmed/30208043
http://dx.doi.org/10.1371/journal.pone.0202589

Ejemplares similares